NDC 44911-0646 – Kidnex IV

Ginkgo 6 [hp_X]/mL; Oxogluric Acid 8 [hp_X]/mL; Anhydrous Citric Acid 8 [hp_X]/mL; Fumaric Acid 8 [hp_X]/mL; Malic Acid 8 [hp_X]/mL; Pyruvic Acid 8 [hp_X]/mL;… · Liquid · Oral

Human Otc Drug

Product NDC44911-0646

Product details

Brand name
Kidnex IV
Generic name
Ginkgo Biloba, Alpha-Ketoglutaricum Acidum, Citricum Acidum, Fumaricum Acidum, Malicum Acidum, Pyruvic Acid, Succinicum Acidum, Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Germanium Sesquioxide, Mercurius Vivus, Nux Vomica, Kidney (Suis), Lymph Node (Suis), Naphthochinonum, Natrum Oxalaceticum, Phosphorus, Urinary Bladder (Suis), Aconiticum Acidum, Cis-
Labeler
Energique, Inc.
Dosage form
Liquid
Route
Oral
Marketing category
UNAPPROVED HOMEOPATHIC
Marketed since
August 23, 2021
Marketing end
July 18, 2028
Pharmacologic class
Anti-coagulant; Calculi Dissolution Agent; Copper-containing Intrauterine Device; Non-Standardized Plant Allergenic Extract; Standardized Chemical Allergen

Active ingredients

Uses, dosage, side effects and warnings for Kidnex →

Package NDC codes (1)

Package NDCDescriptionSince
44911-0646-130 mL in 1 BOTTLE, DROPPER (44911-0646-1)Aug 23, 2021